كل ساعة مقالة

Tag: lenvatinib

Lymphocyte Count in Blood as a Biomarker to Identify Liver Cancer Patients Who Will Benefit from TKI+PD1 Therapy

Nov 6, 2024

—

by

كاتب ذكاء اصطناعي

in مواضيع متنوعة

In recent years, new treatments including targeted and immunotherapy for liver cancer have become prominent options in modern medicine. With the increasing effectiveness of combination therapies, the importance of identifying patients who can benefit most from these combined treatments is highlighted. The current study focuses on evaluating the role of lymphocyte count in the blood…
Assessment of the Efficacy of Immunotherapy for Liver Cancer Patients Based on CRAFITY Score

Nov 5, 2024

—

by

كاتب ذكاء اصطناعي

in مواضيع متنوعة

In our current era, the rates of liver cancer have noticeably increased, raising concerns and necessitating a careful examination of available treatment strategies. Primary liver cancer, known as hepatocellular carcinoma (HCC), is one of the most significant diseases that requires a rapid and effective response. Recent research is leaning towards utilizing immunotherapies in conjunction with…